Vaccine Study
-
Upload
bogdan-heretoiu -
Category
Documents
-
view
217 -
download
0
Transcript of Vaccine Study
-
8/6/2019 Vaccine Study
1/66
Pace Environmental Law Review
Volume 28Issue 2 Winter 2011
Article 6
5-10-2011
Unanswered Questions from the Vaccine InjuryCompensation Program: A Review of
Compensated Cases of Vaccine-Induced BrainInjuryMary HollandNYU School of Law, [email protected]
Louis Conte
Robert Krakow
Lisa Colin
This Article is brought to you for free and open access by the School of Law at DigitalCommons@Pace. It has been accepted for inclusion in Pace
Environmental Law Review by an authorized administrator of DigitalCommons@Pace. For more information, please contact [email protected].
Recommended CitationMary Holland, Louis Conte, Robert Krakow, and Lisa Colin, Unanswered Questions from the VaccineInjury Compensation Program: A Review of Compensated Cases of Vaccine-Induced Brain Injury, 28Pace Envtl. L. Rev. 480 (2011)
Available at: http://digitalcommons.pace.edu/pelr/vol28/iss2/6
http://digitalcommons.pace.edu/pelrhttp://digitalcommons.pace.edu/pelr/vol28http://digitalcommons.pace.edu/pelr/vol28/iss2http://digitalcommons.pace.edu/pelr/vol28/iss2http://digitalcommons.pace.edu/pelr/vol28/iss2/6mailto:[email protected]:[email protected]://digitalcommons.pace.edu/pelr/vol28/iss2/6http://digitalcommons.pace.edu/pelr/vol28/iss2http://digitalcommons.pace.edu/pelr/vol28http://digitalcommons.pace.edu/pelr -
8/6/2019 Vaccine Study
2/66
NDC 30
4
RTILE
UNNSWERED QUESTIONS ROM THE
VINE INJURY OMPENSTIONPRORM
Review of ompensated ases of VaccineInduced rain Injury
YNDUIS CNTT W ND ISCIN
INTRODUTION
Is the Vaccine Injury Compensation Program VICP ofthe US Court of Federal Claims a fair forum? This is not a
trivial question as it is the only forum in which parents may
bring claims for vaccine injury to their children Under the 196
National Childhood Vaccine Injury ct 196 aw Congress
created an administrative forum that it meant to ensure simple
justice for children it gave the VICP original jurisdiction for all
vaccine injury claims1 ecause almost all US children must
ary olland esearch Scholar and Director of the raduate egal SkillsProgram NYU School of aw ouis Conte independent investigator andobert rakow and isa Colin attorneys in private practice Pace aw Schoolprovided significant research support for this study The authors thank formernvironmental aw Dean lexandra Dunn and law students Jillian Petrerayle Caffrey Sohad Jamal lison aplan eorgine ells Jonne onquilloisa atem llison azi and drienne Fortin The authors also thankvolunteers who worked under the direction of ouis Conte For purposes ofdisclosure obert rakow and isa Colin represent clients and have claims onbehalf of family members in the Vaccine Injury Compensation Program
1 National Childhood Vaccine Injury ct of 196 42 USC aa-112 26 ll individuals injured by a vaccine administered after thedate of enactment of the legislation are required to go through the compensationprogram P N 99-9 at 196 reprinted in 196 USCCN644 644 fter filing in the program petitioners may reject program
judgments or opt out of it to bring claims in state or federal court but initialclaims over 1 in damages must be made in the VICP Id at 12
-
8/6/2019 Vaccine Study
3/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
K>BO>O:MH:MM>G==:R:G=L %, A:L A:= : BQ>= ABLMHKR BG MA> >R>L H MA>
:BEB>LHMA>O:=
BMBLH MHLM BHKM:G MA:M MABL MKB;G:E KHOB=>L >BM:;E>MK>:M>GMMK:GL:K>GGAHA:O>
MA>@K:O>BLHKMG>MH;>BGK>=;RMA>O>KRO:G=>=MH>>MA>A>:EMAR
3ABE>LH>:K>GMLHO:=GLHKM>=MA>(:HO>KMB>:GRMH
OB>BMBMA;BMM>K=BL:HBGM>GMXEK>:=R;RMA>B=ZL$$/ A:= K>== MA> @KHG=L HK K>LMBO> KR HK O:KO>KLHG= MKH;EBG@
0A:M G@> ;>@:G BG A>G G>:KER BO> MAHL:G=
:BEB>LBE>=>MBMBHGLBMAMA>%,KHEH@BK = :MBLX
M MA> %,ZL @K>:M>LM G@> R>M E:R:A>:=
&// &>+>/ %/;?3= *0%+*( *!03+.' "+. %))*%0%+*AMMBGB:MBHGBGHHK@O:K>BK>>GML E:LM OBLBM>= ">; KHOB=BG@ : L>:K EBLMH O:BK>>GMLHK G;RLM:M>
/M:KMBG@ BG MA> E:M> ZL MA> K>>GL
&// /1 KB> HK MA> *:MBHG:E :GM>K >M :E :LB /HKMBG@ ,>MBMBHG>KL K>L>BM O 3R>MA /M *H +@+36+,6/ +> AMM:>KBOB>;EB=K>OB>;KB>L=L,>MBMBHG>K*%:G=+K@L:MAM>LMBHGRH:K;:K:(H>"BLA>K;>HK>HG@K>LLBG 0A>K> BL ;BMM>K =BL:HBGM>GM :G= >KO:LBO> GA:BG>LL :HG@:K>GMLBMAMA>GMLMK:G=:=BGBLMK:MBHGHMA>O:HO>= MA> K>LMBHG H K>KR KH K>LB=:E L>BK>=BLHK=>KX BG ):K MA> K>L>BM :BER BG
-
8/6/2019 Vaccine Study
4/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
;>@:GMHLRKHM %G:GGK>=>GM>=KH>=BG@MA>%,:M>= :G= +GB;L MBL ,KH>=BG@=A>:KBG@L>:GMMH;KBG@LMBMHMA>L>
%, =BLBLL>= :EE MA> M>LM X :ELHKMA>">=>K:EBKE=:EEMA>=>OB>
>LBM> ::K>GM =B=>:BGK>MA>LH:MBLX
MA:MMA>%,K>>=BGMA>+GB;L MBL,KH>=BG@K>:EER=B>K>GMKHMA>LH>GA:EH:MARX:G=K>LB=:EL>BK>=BLHK=>KXMA:MMA>%,A:LGL:M>=;>HK>:G=LBG %LBMHLLB;E>MA>%, K>>=LH:MBLX;>H MA>AHM;MMHG E:;>E :G= GHM ;> H K>:E =B>K>GL BG BGKB>L HK>OB=>G
0ABL K>EBBG:KR LM=R L@@>LML MA:M MA> %, A:L ;>>GGL:MBG@ L H O:GA:EH:MAR :G=
K>LB=:E L>BK> =BLHK=>K :LLH= BMA :MBL LBG MA>BGMBHG H MA> KH@K: 0AKH@A MABLK>EBBG:KR LM=R MA>:MAHKL A:O> HG= >B@AMRMAK>> L H :MBL :HG@ MAHL>GL:M>= HK O:
0ABL :LL>LL>GM H GL:M>= L LAHBG@ :G:LLHM>>G O:L GHMKHKM MH ;> LG %G GH :R =H>L BM >QE:BG LGMBBG G>LL:KBER G=>KBG> MA> K>:LHGBG@ H MA>
=> +GB;L MBL ,KH>=BG@ ;:L>= HG MA>LGMBBHKB>L :G= >=BOB=>G ;>HK> MA> %, *HK=H>L MABL :KMB A:O> :GRMABG@ MH L:R :;HM LM:M> LBG@>G>K:E
0ABL BG=BG@K:BL>L G=:>GM:E>LMBHGL:;HM MA>BGM>@KBMR MK:GL:K>GLLHMABLHK
3A:M MABL :KMB =H>L HBGM MH :K> G:GL>K>= >LMBHGL:;HM O: MA:M :>
-
8/6/2019 Vaccine Study
5/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
:KHQB:M>ER HG> BGHG>AG=K>=:G= M>GG+GMABLHBGM MABL LM=R LMKHG@ER L@@>LML MA> G>>= HK KMA>KHG@K>LLBHG:E :G= LGMBBLMB@:MBHG MH >QEHK> MA>
:LLHM>>GO: BGM>@KBMR H MABL >=>K:EER:=BGBLM>K>= GL:MBHGKH@K:
%G,:KM%>K>OB>MA>(:MA:M:M>=MA>%,:G=MA> +GB;L ;:
>:KM>GMH$>:EMA:G=$:G/>KOBLZ$$/X#96381:G=:MM>MLMH@>MBGHK:MBHG:;HM:MBLKH GL:M>= L H O:M:BEL MA>;EBLA>= L BG MA> %, MA:M GHM> :MBL HK :MBLEB>LRMHL :G= BGHK:MBHG :;HM L>MME>= L :GB>LMBG@:MBLMA:M:K>GM:E@BO>KLA:O>=%M=BLLMA>
L :G= BGL K>K>L>GM:MBO>>LMBHGG:BK> K>LHGL>L KH:K>GML :G= @BO>KL ,:KM %%% AB@AEB@AML G:GL>K>=>LMBHGL :>L K>G=:MBHGL :G= =K:L QKMLKH : "K>>=H H %GHK:MBHG .>>LM : EBLM H K>OBHLER;EBLA>=:KMBL>O:E:MBG@GL:M>=LKHMA>%,
:G=::K>GMLMK=BGM>KOB>HK
&///+>??.C8@/=>K:EE:BLHBGMERHO>KL>>MA>%,.
http://digitalcommons.pace.edu/pelr/vol28/iss2/6
-
8/6/2019 Vaccine Study
6/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
(*"")&-#!$"'(#"$&!*$"(#!")')('!$"
(52*$.;1A52".A6 %, :L :KM H MA> *:MBHG:EABE=AHH=:=MABLE>@BLE:MBHG MH :O> L>O>K:E H;>L MH :M> MA>
BGK:LMK HK : G:MBHG:E BGB:MBHG KH@K: MHBGLE:M>BG=LMKR:G= MA>>=BLLBHGKHEB:;BEBMRMH >LM:;EBLA : KH@K: MH GL:M> MA> BGK>= :G= MHKHHM>L:>KO: (: HMEBG>= :G :;BMBHL :@>G=: HK O:L>:K= MA> %, MHGL:M>O:E:M>= BGKR HK =>:MAX %G BML E>@BLE:MBO> ABLMHKR
HG@K>LL :LL>KM>= MA:M MA> KHL> H MA> KH@K: :L MH>LM:;EBLA:>=>K:EGH:EM KH@K:G=>KAB MH O:= >KLHGL B:LBER :G= BMA
KM:BGMR :G= @>G>KHLBMRX HG@K>LL >G:= MA> LM:MM> MHGL:M> G AH A:= ;>>G BGK>= ABE> L>KOBG@ MA>;EBKH@K:K>BK>L:K>GMLHO:=GMHBE> BKLM BG MA> %, ;>HK> :GR HMA>K HKM H
">=>K:E E:BL BG 3:LABG@MHG HO>KL>>L MA> KH@K: *:MBHG:EABE=AHH=:
-
8/6/2019 Vaccine Study
7/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
M>KBEBG@BGMA>%,AH>O>K>MBMBHG>KLK>M:BGMA>KB@AMMH@H MH = >KBH= H MB> HKK>>LLBGM>G=>=MH:M>:E:K@>ER
:=BGBLMK:MBO> KH@K: :L :G :EM>KG:MBO> MH MA> 0A>KHL>HMA>%,:LMH>LM:;EBLA:>=>K:EGH:EMX GL:MBHG KH@K: 0A> HG@K>LLBHG:E HBMM>>
.>HKMGHM>=MA:MMA>LRLM>BLBGM>G=>=MH;>>Q>=BMBHL:G=:BKX :G= MH GL:M> K>= O:L BMAHMK>BKBG@MA>=BBM>KBG:MBHGL H KHL> H MA> LM:MM> :L MH HO>K MA>BG:=>:L H MA> >QBLMBG@ MHKM LRLM> HK O:=G7"8HKMA>K>E:MBO>ER>AH:K>BGK>=;RO:BKHGMA>HHKMGBMB>LHKK>=K>LL:G=K>LMBMMBHG :K> EBBM>= MB>Q>GLBO> :G= HM>GG:GL>K>= 5>M MK>LA:O> ;>>G=>LMKHR>=:G=HGMBG@>Q>GL>LLM;>>MX
3A>G HG@K>LL :LL>= MA> (: MA>K> >K> L>O>K:EK>= O:L BGGA:EH:MAR:K:ERMB=BLHK=>K :G= =>:MA
EE MA> BGKB>L HG MA> :>K>MHA:O>H0:;E>=>L=>O>GMLMA:MLMH=:RL H : BOBG@ : O:MBMBHG>KL>MMA>>Q:BK>>GMLH MA>L>=BGKB>LMA>G MA>R HE= GHM ;> K>BK>= MH EBMB@:M> :G= HE= K>BO>GL:MBHG MAKH@A :G :=BGBLMK:MBO> GH:EMX KHLL
.::
$..!,*+:M0A>HBMM>>7HG!G>K@R:G=H>K8:GMBL MA:MMA> L>>= H MA>GL:MBHG KH@K: MA>EH MK:GL:MA>GH:EMG:MK>HMA>K>BK>=BG=BG@L:G=MA>K>E:MBO>KM:BGMR:G=@>G>KHLBMRHMA>LRLM>ZL::K=LBEE=BO>KM:LB@GBBKHHM>GMB:EE:BGMBLKHEBMB@:MBHGX
.:M
.:M
&// ,( /M:M = :L :>G=>= :M / :: +@+36+,6/ +> AMMAKL:@HOO:@BLE:MBHG=
. ,:K:ERMB>KBH=H =:RLHLM BGKB>L>K> MHA:O>H
-
8/6/2019 Vaccine Study
8/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
"HK BGKB>L MA:M >K> GHM EBLM>= HG MA> 0:;E> AH>O>K>MBMBHG>KL HE= A:O> MH KHO> MA>L> BGKB>L ;:L>= HG :K>HG=>K:G H MA> >OB=>G : HK> EB>ER MA:G GHMX
LM:G=:K=
0A>%,BGLE:M>LO:BK>LMA:M>MBMBHG>KL;KBG@MA>BK>MBMBHGLLHE>ER:@:BGLM$$/0A>R :R GHM L> :G:KL HKA>:EMA K:KL
0A>K:MBHG:E>HKMABLBG=LMKR:G=KH>LLBHG:EKHM>GLK> : LM:;E> KBL:HK=:;E> 0A>%, ::K=L GL:MBHG HM H : :=>K:EE:BL!B@AM/>KL:LHE>BG=>KLH:%,BL>:GMMH;>BGHK:EBMAHM K>EB:G HG MA> >=>K:E KE>L H >OB=>G :G=
*:MBHG:E ABE=AHH= :G=>= MABL BGHK:EBMR MH ;>G>BM MA>
.:::=//+6=9$..!,*+:M;BEEK>BK>LMA:M:>KLHGBMA:GBGKRK>LEMBG@ KH : O:K>= :M>K MA> >G:GM H MABLE>@BLE:MBHG BE> : GL:MBHG >MBMBHG :G= @H MAKH@A MA> GL:MBHGKH@K: ;>HK> KH>=BG@ BMA +8C EBMB@:MBHG :@:BGLM : :G:KX>A:LBL:==>=
&///1/M>O>,:E:G=KBEEH)+83=2381)+--38+>398=*2C90)+--38+>381'2/3
-
8/6/2019 Vaccine Study
9/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
>MBMBHG>KL ;R :BG@ MA> HK LBE>K :G= E>LL />KL =H GHM L>KO> :L K>=>GM BGL;L>>GMKH>=BG@LBGLM:M>HK>=>K:EMBMBHG>KL:RK>BO>BG MA> >O>GMH:O:E:M>==>:MA:G=::QB:HGMHHK:BG:G=L>KBG@
0A>L>GHM=LBG0A>(: :ELHKHOB=>L HK K>:LHG:;E>:MMHKG>RZL >>L:G= MBMBHGLHMA:M>MBMBHG>KL=HGHMA:O>MH:RE:R>KL
HMHHMHKHMHMA>KH>=LH: =@>GM:LMA>RHE=A:O>MH=HBG:KK:G@>>GM
0A>(:K>BK>LMA:M>MBMBHGL;>BE>=7GHHK>MA:G8HGMAL:M>KMA>=:M>HMA>HBKLMLRMHHK:GB>LM:MBHGHHGL>MHKH MA> LB@GBB :=BGBLMK:MBHG H MA> O:>R>:K LM:MM> H EBBM:MBHGL BL LAHKM>K MA:G :GR LM:M> MHKMLM:MM>L:G==H>LGHMKHOB=>HKMHEEBG@A>GE:BGMBL=B=GHM
HKBGKRBMABGMA>MAK>>R>:KLM:MM>HEBBM:MBHGL
%G>KA:LMA>HLMLB@GBBLM:MM>MA>(:K>LMKB BKLM BGMA> %,
$..>*H:M0A>KHL>HMA>LM:MM>BLMH>LM:;EBLA:">=>K:E GH:EMZ GL:MBHGKH@K: G=>K AB MHO:=>KLHGLB:LBER:G=BMAKM:BGMR:G=@>G>KHLBMRX
/ ::ABLMA:MBGHK:MBHGL;BMM>=
MH : L>K HK MA> =BG@ HG : >MBMBHG :R GHM ;>=BL=MH:>KLHGAHBLGHM::KMRMHMA>KH>=BG@BMAHMMA>>QK>LLKBMM>GGMHMA>>KLHGAHL;BMM>=MA>BGHK:MBHGX%GHMA>KHK=L:EEK>L>:E>=:G==HGHM;>:KMHMA>>GMG=>=:M/::: +@+36+,6/ +> AMMAKL:@HOO:@BLE:MBHG=
&///::>
.::
EH>KO/>:EMA$:G/>KOL">=E">=E HG>BM:;E> MHEEBG@:G==BLKR H BGKR BGO:HK> MA>HKM H>:EL HK MA> ">=>K:E BK:KBG@MH;>A>:K=BG&//EH>KO/>:EMA$:G/>KOL*H3(">=BK+
-
8/6/2019 Vaccine Study
10/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
/M:KMBG@ BG GH O: HK :O:E:M>= BGKR HK =>:MA KH HG> H MA> K>G=>=O: BGKR HK =>:MA K>LEM>= KH LB=> >>K>G:OHB=:;E>>O>GMAH@AMA>O:KERK>:K>=:G=:L:K=BK>LM>LKHMA>/>LM:M>>GMH0HKML0A>/
/K>> HKM =>=
-
8/6/2019 Vaccine Study
11/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
:>=BHKR>
O::LHGHKMA>BGKR:G=:LAHBG@H:KHQB:M>M>HK:EK>E:MBHGLAB;>M>>G
O:K>:LHGHKMABLEH>K;K=>GMA:GMA:MG>LL:KRBGK>MHM>:G==BK>MBMBHG>KL:K>GHMK>BK>=MHLAHMA>K>>>K>ERK>BK>=MHLAHMA:MMA>O:LMBHG = MA>BK BGKR X
(52*.006;2BA6@:=BGMA>+GB;L:LBM=H>LBG:EE%,L
: ;>>G KLB:E LBG !=:K= &>GG>KBGBMB:M>=MA>BKB=>LK>:=L>BG!G@E:G=BGMA>L/H>:K@> MA:M MA> HK:KR / HO>>GM HK O:MR:G= @:G BMA (>:0AHLHGZL M>E>OBLBHG L>G/BEE>RO/>:EMA $:G/>KOL">=E">=E
"HK ABLMHKR H KLR :;HM O:> .H;>KM &HAGLMHG98>/7:9398 9@/7/8>= 38 3=>9KM&HAGLMHG>=
&//#')+--38/%9?6/>>/*M>E>OBLBHG;KH:=K>BG:M>K!(5$+%!/8
http://digitalcommons.pace.edu/pelr/vol28/iss2/6
-
8/6/2019 Vaccine Study
12/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
MA> E>:=BG@/ O:MR HK@:GB:MBHG 0AKH@AHM MA>E:M> ZL :G= >:KER ZL *% ;EBKB@AM MH BGHK>= GM HK O:
KBLLHO:K:G=:K;:K:(H>"BLA>KZL;HH /$+0 %*0$!.':;HM:=O>KL>K>:,0O:LMBHG>= MA> MR
0A> / O: BG MA> E:M> ZL %G
HG@K>LL:G "K:G ,:EEHG> H *> &>KL>R :MM:= :G:>G=>GM MH : "HH= :G= K@ =BGBLMK:MBHG "XK>:MAHKB:MBHG;BEEK>BKBG@MA>"MH:EBLMH=K@L:G= HH=L MA:M GMBHG:EER BGMKH== >K :G= :EBM:MBO>:G:ERLBLHMA>>K;BEEE:M>K
>OHEO>=BGMHMA>")H=>KGB:MBHG>LML ;R KHOB=BG@ =>M:BE>= BGHK:MBHG :;HM MA>BK>K MAB>KHL:E
0AB>KHL:EA:=;>>GL>=:L:K>L>KO:MBO>BGO:L;>HBMLLMKHG@:GMB;:KB:EKH>KMB>L0A>L>HMAB>KHL:E :EEH>= O:O: :ER;R:BGEMBL>OB:EL
*0Z(%*! %*"+ 0. AMMGOB= &:G
/>O>K:EHMA>O:KHMBG>
&//1/8/KGB:MBHG
-
8/6/2019 Vaccine Study
13/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
=MAB>KHL:EBG=BAMA>KB:M>M:GL>KMLLBLKOB,$/XH$$/:G= MA>
>KB=B:MKB=:HBGMLM:M>>GMHGMAB>KHL:EBGO:=
,$/:G=,MHK>G=MA:M:EEGLAHE=;>
BGB>= :@:BGLM MA> =BL>:L>L BG=B= BG MA> K>G=>=
BGB:MBHGL=E>#BO>GMA:MMA>KBLLHGHMO: GGHG :G= K KBL B
:GRH>QHLK>MHMAB>KHL:EBKLM
HGMAL H EB> >G= MH
BGB> :EE BG:GML >O>G B MA> K MA> HBGM LM:M>>GM :K>GML H :MBLMBKK>= MA> HLLB;BEBMR MA:M >KO>EH>GM:E K>@K>LLBHGMAKH@A : GB> HKH>KO>K:E:MAHKL ;EBLA>= :G :KMB BG)!%( $5,+0$!/!/ >GMBME>=
?>3=7 + 89@/6 09LEMH>K@:GMHBE>E:LBML:KHG=MA>,0O:KHL:E)).GHM:;ER=H>LGHM KHL:E ;> BM OBKL>L MA:M MA> MAB>KHL:EB@AM HMA>KBL> BEE "HK : EBLM H KHL:EGML>>3.:M0:;E>
/BG MA> E:M>
ZL MA> O:;:M> A:L = BMA G>
,;$>:EMA/>KO/>ZMH$>:EMA$:G/>KOL'237/ &>+>/7/8> 90 >2/ 7/2/
#?,63- /+6>2 &/ 90)+--38/9?)(.!
http://digitalcommons.pace.edu/pelr/vol28/iss2/6
-
8/6/2019 Vaccine Study
14/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
=>O>EH>GMLBG>=B:G=LG:G=BMA:MAHKLM:BG@HLBMBHGL;HMAHK:G=:@:BGLM:HLLB;E>O:MBO>ERLBE>>LMBHGBL:MMA>
A>:KMHMABLKH;E>0H=:R:MBLMBKXBLK>=:LR3-+8.&>+>3=>3-+6+8?+690/8>+6 3=9>K>G HK MA>GML BG LHK:GML BG O>K;:E :G= GHGO>K;:E HMRBLMKB= HK K>>MBMBO> :MM>KGL H ;>A:OBHK :G=BGM>K>LML 0A>K>:K>GHGBO>KL:EER:=;BH:K>KLL>
=H:BGLH =B:@GHLMBL> :EHLM GH LHK:O>K> ;>A:OBHK:E KH;E>L MH >QMK>>ER AB@AGGL> BGM>K>LML :G= BKR>KLHG:EBMB>L 0A> K:G@> H :MBLMBKL BG MA> /)%HK:EER BGL :MBL .>MMZL BLHK=>K ABE=AHH=
BLBGM>@K:MBO> BLHK=>K L>K@>KZL /RG=KH> :G= ,>KO:LBO>>O>EH>GMBLHK=>K*HM+MA>KBL>/>=,*+/X
"HK : K>OB> H LGMBBL LHKMBG@ : HLLB;E> EBG ;>M>>GO:3:>B>E=8(+66 09=
.:M &//3.:M
-
8/6/2019 Vaccine Study
15/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
>:MBLMBKBL=>BG>=HGER;R:G:@@K>@:MBHGHLRMHLMA>K>BLGH>:GBG@E=BLMBGM>>GMA>M>KL:MBLX :G= :MBLEB> LRMHLX 0ABL :KMB :>L MA>
=BLMBGM>KLMA:MMA>HKMH">=>K:EE:BL@BO>KL:G=HMA>KLL>%MBLGHM:=BLMBG
-
8/6/2019 Vaccine Study
16/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
EMAH@A MA>K> A:O> ;>>G BLHE:M>= ABLMHKBKGA>GH>GHG:LBKLM=>L=;R
3=7 /HKB@BG:E
G BG ':GG>KZL L>KB>L
':GG>K BKLM GHM>=:GRHMA>LRG=KH>B:BK>= E:G@:@> LH>MBMBO> ;>A:OBHKL M
ABL E L>KB>L :G:ERLBL :BE>= MH :L LB@GBBE:M>= LRMHL BG>=BG@ :MM>KGL:G= @:LMKHBGM>LMBG:EKH;E>L BG MA> G :G= A> :BE>= MHEHH :MHLLB;E> >GOBKHG>GM:E >QHLK>L MA:M B@AM A:O> ;>>G B=>GMBB>=G BGMA> L>KB>L A:= >Q>KB>G= GHGHKE:LB;E>>QHLK>L MH >MARE >KG G>ER:M>= LRGMA>MBBG;HMAO: L>KB>LA:=:K>GML>BMA>KBGMA>>=BLLBHGHKBG@HGO:GMLBG:@KBLBG@G@BL 3ABE>MA>>KK> :K> :GR LHKLBG +ELM>=E:QBEE ;HH MA:M @BO> MA> ARHMA>LBL
E:LB;BEBMR
,BK?>3=>3-3=>?3@/98>+->*!.+/$%( +@+36+,6/ +> AMM:>=B:BM>=.@K:=LKMBL=L':GG>K+KB@,:>K=
&// * +()/0! ).' (%(( 0$! #! +"0%/) )!..5)!%%*!*)*)!!,%!)%
.:M
&//3.:M
&//3.
+MA>K K>GM LM=B>L MA:M GHM> E:MBHGL ;>M>>G >KK>GOBKHG>GM:E MHQBGL:G=:MBLBG):KR:MA>KBG> >/HMH .H;>KM0$BME:G&9381"?>>2/&:38838190?>3=7/+@C/>+6=+8.>2/$?/=>398908-3./8-/ 0 *!.+%+(+#%! !,!.%)!*0(%/ ):KR:MA>KBG> >/HMH "-52+7G=%+D93=7 '2/+=/ 09+6!/?9B38= 98>381 >9 + 3=/+=/ 90 !/? *!.+0+%+(+#5 .:RHG= " ,:E>K >M :E#C >9 #938>&9?
-
8/6/2019 Vaccine Study
17/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
+G> LM GHM> MA:M MA> /)% =>BGBMBHG H :MBLMBKX BL LBBE:K HG BML : MH MA> %,ZL =>BGBMBHGL H>GA:EH:MARL>BK>L:G=L>>E:X
>:L>=HK:;L>GMK>LHGL>MH>GOBKHG>GMK>LHG=LB:M
:EEHGERMHEH=OHBHK:BGELMBEB
0A>%,ZL=>LGA:EH:MARHKG>B@AM>>GHGMALH:@>:G=HE=>K BG=E>O>EH /)%ZL KB: HK HGL>M ;>HK> :@> MAK>> H :MBLMBKX0A>=B>GLBHGLH:MBLMBK:K> %,ZL =>M:BE>= =>L:L>= E>O>E H:L>=HK:;L>GM>R>HG:BER
>;>KLHKHMA>KBG=BOB=:ELHK
%GGMHK:;L>GMK>LHGL>LMH>QM>KG:ELMBEB=H>LGHM
K>:BEB:K>HE>HKMABG@L
%G HMA>K HK=L E:R> @:> B:BK>= LHE:MBHGL:G=GHGK>LHGLBO>G>LLMH>QM>KG:ELMBEB:K>GHM>=BG
;HMA MA> /)% :MBL :G= %, >GA:EH:MAR /)% %, =>LL GHM LGA:EH:MAR L>BK>L :G= L>>E: %G=>>= LGMBBK>LMBG@MA:M':GG>KABL>EGHM>=MA:M:;BHEH@BMBHEH@R H:MBL B@AM A:O>;>>G HO>KEHH>= %G MA> HK>HK= MH!.*. .%)(* %*"*0%(!/0%) /5*.+)! * %0/ %),(%0%+*/ "+. *!.(0$!+.5+"!$%+.':GG>KKHM>
0A>:KERBG:GMBE>:MBLZ%MM>KG:>:L=BEM>=;R LH>MH=>KBO> BMH BMLL>K:LL>= :L:L>=H=B:@GHLMB;:L>M HK : O:KB>MR H GK>E:M>= = ;R LH> :L MA> HGER O:EB=>QE:G:MBHGLHMA:MKMA>K=HK>O>GL=
.:MO
&//380G=BL%:G=%% 97:+2380G=BQ%%
http://digitalcommons.pace.edu/pelr/vol28/iss2/6
-
8/6/2019 Vaccine Study
18/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
EBM>K:MK> :=@>L MA:M MA> G QBLM
(52#:;6/B@BA6@:$?L> =>LG M LB=> ;R LB=> LAH LB@GBBL
":BEB>L :EE>@BG@ O:= E:LBML:@:BGLMO::G=>=>K:E HKM H ">=>K:EE:BL /ER >G=>= LMA>E>LL BO> MAHL:G= >MBMBHG>KL BE>= %, H O:KHL:E :G= )).HKB>L0A>%,=>=BMHE=AHE=A>:KBG@LHGMA>L>MHM>LMMA>HKB>LBMAMAK>>M>LMLXHK>:HKRMH
=> @>G>K:E =KHBEBG@ ;> MA> LMKB>R>:K LM:MM> H EBBM:MBHGL A:=>QBK>=%G:==BMBHGLH>>MBMBHG>KLBE>=BGMA>%,:G=MA>GHO>= MA>BK L MHLM:M>:G=>=>K:EK MA>K>BK>=
:BMBG@>KBH= MH;KBG@ E:LBML:@:BGLMO:MA>HKRHO:LB@G=>>KHK>MA>R:GM>=MHEBMB@:M>BGK>@E:K MA>R HE= >GHR KB@AML MH =BLKRHM>GMB:EERAB@AGL:MHKR:G=GBMBO>=::@>L:G=KB>L
*HG>HMAHL>=B>GLBHGL:K>:O:BE:;E>BGMA>%,
&///1/!KRLHG>M:E#3=77981.96/=-/8>=A3>28>/66/->?+63=+,363>3/=*&,/5$%0.5.03=7(*!0*!.+(+#5
&//(>KHRO/>>ZMH$>:EMA$:G/>KOL*H 3( ">= E +AMMLL:MBL(>KHR=
&///1$H>,KH=LHKO">KK:KB /!=#:
-
8/6/2019 Vaccine Study
19/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
+G">;K:KR/>KLHMA>">=>K:EHKMH E:BL K>E>:L>= EHG@::BM>= => BKLM+GB;LMBL,KH>=BG@M>LML0A>/>KLKE>=MA:M
MA>K> :L GH E:LB;E> EBG ;>M>>G MA> )). O: MAK>> M>LM X >MBMBHG>KL HK MABLHKR)BEE> >=BEEH HEM>G /GR=>K :G= 5:M>L
$:E>AKLM=>L>KO>=GHGL:MBHG0A>/>KL=B=GHMLBERLG=BL:OHK>=>MBMBHG>KL0A>RBLL>=L>=:G==>>:G>=>MBMBHG>KLZLGMBBHKB>L>Q>KMBMG>LL>L:G=MK>:MBG@ARLBK $:LMBG@L KH= MA:M MA> >=BEEH :L HG>LB=>=X MA:M MA> =H=)BEE> >=BEEH>K> @/ KHM>MA:M MA>ARLBM>>G)BEE>ZLL>O>K>:E:=B>L
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
.:M
/GR=>K O />:EMA $:G />KOL *H 3( :M ">= E ">; +@+36+,6/ +>AMMLLO:LH>EE/GR=>K= &///.36693(:M
http://digitalcommons.pace.edu/pelr/vol28/iss2/6
-
8/6/2019 Vaccine Study
20/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
:MBL:@:BGBG=BG@GH;:LBL HKGL:MBHG 0A>L>MAK>>M>LM>MBMBHG>KL>E>=GHMMH:>:EMA>BK=>:K@BG@)).BG==:MBLBGMA>BKLML>MHM>LML
;HMA>=BEEH:G=$:E>AKLMEHLMHG:>:E :G=/GR=>K=B=GHM:>:E
0A>HKMH>:ELHKMA>">=>K:EBK+D6/2? @ & HK:E :K@>GM MA> =@>L :GM>= MH GH
A:M HE= A:>G B E:M>K LG MAB>KHL:E:MBLMA>HKR
3A:MBEEA:>GMHMA>GZL=@>:GL>K>=ABLHG>LMBHGL:RBG@MA:MHG@K>LLKHL:EBG==:MBLMHMA>0:;E>H%GKB>L:G=LM:M>MA:MMAHL>AHA:=K>OBHLER;>>G =>GB>=GL:MBHGHE= LMBEE;>>EB@B;E>
/BBE:KER MA> :G>E H :>EE:M> =@>L BG /.3669 @ &
:L>=MA>>:KM>GMH&LMB+&XMH@A>LMBHGL
0A>:>EE:M>LL>>>=GHMMHBG=MA>
O:HKR:LBE:LB;E>:LA:=MA>/>KL
&// )>:= O />:EMA $:G />KOL *H 3(">=E@'BG@O/>:EMA$:G/>KOL*H3(">=E):KR>KO/>:EMA
$:G />KOL*H 3( ">= E ):K EEMAK>> L :K> :O:BE:;E> HGEBG> &// ?>3=7 /-3=398= +8. +-51>=@>L>K>:KERMKH;E>=MA:M+&A:=BGMKH==:G >Q>KM K>HKM MH K>;M >R >MBMBHG>K ;BHEH@BOB=>GBMAHM BGMKH= G=>KERBG@ E:; K>LEML HK ;HHLLH>MABG@ MA:M :EE :KMB>L :@K>>= HE= A:O> ;>>G BHLLB;E>
>=BEEHO/>:EMA$:G/>KOL"=">=BK +@+36+,6/ +> AMMLL=BEEH>=AKLMO/>:EMA$:G/>KOL "= ">= BK +@+36+,6/ +>AMMLL$:E>AKLMBK:G=
&//&8C./AKLMO/>:EMA $:G/>KOL "= ">= BK +@+36+,6/ +>AMM:EMA$:G/>KOL*H 3( ">= E ">; +@+36+,6/ +>AMM
-
8/6/2019 Vaccine Study
21/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
G=>K MA> ">=>K:E .E>L H BOBE ,KH=K> 0A>R KH;>=A>MA>K+&A:=:L>=HKMA>E:;;HHLMA>RA:=GZMHKAH+&LK>MA:MMA>>Q>KMK>HKM:LK>EB:;E>A>G+&
=B=GZMA:O> MA>G=>KERBG@=:M: A>G MA>+& E:R>K:LLK>=MA> =@> MA:M MA> =:M: HE= A:O> K>BGHK= MA> >Q>KMZL E:@A>= :L =B= H;L>KO>KL BG MA>
=@>L >K> LBBE:KER MKH;E>= MA:M +&:BE>= MH GHMBR >MBMBHG>KL MA:M MA>R >K> L>>BG@ MA> >Q>KMK>HKM BG MA> BKLME: :L LK>ER +& LAHE= A:O> ;>>G >EE::K>MA:MLKKBL>:L:G>GMBK>ERBG:KHKB:M>M::GM MH;>>MBMBHG>KKB>G=ER :G=GHG:=O>KL:KB:E 3ABE> MA> :>EE:M> =@>L BG ;HMA +D6/2?
:G=/.3669=>=BG:OHKH$$/:G=:@:BGLM>MBMBHG>KLMA>R=B=LH:M>K GMBHLHK:E :K@>GM :G=MA>=@>LGHM>= BG/.3669@&MA:M+&ZL
M>KMA>BG:E+GB;L:>:EL>K>=>=BGMA>L>KH;R:EE:>:K:GLMA>O:%,:L =0A>HKM H">=>K:E E:BLL>GMHM E>MM>KLMH:EE>MBMBHG>KLM>EEBG@MA>BGLH:GRHK=LMA:MGE>LLMA>R@> =B>K>GM MA>HKB>L :G= KHOB=> EEBG@ >Q>KML :G=>OB=>GMA>BKLHE=;>=BLBLL>=BMAHMA>:KBG@HGMA>;:LBLHMA>+GB;L@>G>K:ELML
.
.
.
.
>=BEEHO/>:EMA$:G/>KOL"=">=BK +@+36+,6/ +> AMMLL=BEEH>=AKLMO/>:EMA$:G/>KOL "= ">= BK +@+36+,6/ +> AMMLL$:E>AKLMBK:G= 3> :@K>> BMA >MBMBHG>KL MA:MMA> @HO>KG>GML :BEK> MH KH= HK >O>G MH K>>LM MA> =HGM:MBHGG=>KERBG@ K LMBGL K>HKML BL MKH;EBG@ ;M > MABG MA:M BG MA>LGHMLMBRK>O>KL:EX
&//MBL=:M>/>M>;>K8LEMBG@ BG MBL />K HK : /BBE:K *>KH=>O>EH>GM:EBLHK=>K 3( ">= E &ER +@+36+,6/ +>AMMLL:MBL:MBL=:M>= +.0 +" "! (%)/ #%*! 0+,!0%0%+*!./ +* $+3 0+ !%0 0$!%*! ,.+#.) +@+36+,6/ +>AMMLL:MBL!%0%*##%*!0+,.+/!/=
http://digitalcommons.pace.edu/pelr/vol28/iss2/6
-
8/6/2019 Vaccine Study
22/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
(52$L>MHM>LMLBGMA>
+GB;L MA:M HE= K A>MA>K MAB>KHL:EGM HHMA>LE:M>=M>LML%G:K>HKMK>BK>=;R HKM .E> :>= MH MA> K>LL $$/ = MA:MO:K>= $:GG:A ,HEBG@ZL>GA:EH:MAR :G= L;L>>GM =>O>EH>GM:E K>@K>LLBHG$$/ZL =>L >G :MBLEB> LRMHLX :G= :MBLX :EMAH@A MA>K>:LGH:;B@BMRMA:M$:GG:A,HEBG@BG:M
MA> LM:MMHKR KB: HK =>HGLMK:MBG@ MA:M MA> O:= HG &ER LB@GBB= :G
G=>KERBG@ BMHK AB=BLHL>= A>K MH=>BG>K@R >M:;HEBL :G= :GB>LM>= :L :K>@K>LLBO> >GA:EH:MAR BMA >:MK>L H :MBL L>KX0ABL=MHLH>BGM>K>LMBGMA>K>LLHG
MA> O: KHE> H BMH @/= MA:M $$/ :B= HO>K
&HG / ,HEBG@ >M :E /@/69:7/8>+6 %/19-298.39838+236.*3>2?>3=7&+"$%(*!.+(+#5
&//'BK;R=?:;KB>>QKMKHMABLHKMBL:ELH:O:BE:;E>:M,HEBG@O/>:EMA$:G/>KOL *H3(">=EK%MBLGHM:;E>MA:MMABLBGBMB:EHKM >K>ER >GMBHGLMA> )). O:GL:=BGBLM>K>= MH$:GG:A ,HEBG@ BG HG> HB OBLBM A>K>:L MA> BG:E GL:MBHG =>= ;>EH BG MA> ,;EBLA>= :L> A:KM :L :L> L>L )). :L MA>KBGKBGKR
&// #BG@>K 0:REHK '2/ %96/ 90 9@/ +8. /.3+ 38 %*!!,%!)%$+3+.,+.0!#.!!%/!/%!*!*+!.%!#+!.*)!*00$.!0!* +. $)* .%#$0/ +. $!(0$ * +. $%(.!* (HBL>'H$:;:L):KR$HEE:G=>=L
-
8/6/2019 Vaccine Study
23/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
BEEBHG BG =::@>L 0A> K>E>O:GM %, >;LBM> GHM>LEER AH>O>K MA:M ABE> HG> K>BO>= GL:MBHGKH MA>+GB;L$$/A:LG>O>K HMA>K BO> MAHL:G= >=A:M:=>MA>:MM>K:KMBEB>= HG MA> O>KR
L:>>=BQ>KM:BG@MA>O>KRL:>>=B MA>#96381 :G= MH=BLBLL HG> HMA> M>LMLBMAHMMA:M>Q>KM>O>K;>BG@Q:BG>=HKM>LMBRBG@BG>KLHG BGMA> +GB;L:;HM MABL ::K>GM
-
8/6/2019 Vaccine Study
24/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
GL:M>= HK O:R>EBG:MBG@>GA:EHR>EBMBL !)X E>:=BG@ MH ,>KO:LBO>>O>EH>GMBLHK=>K*HM+MA>KBL>/>=:G:MBLMBK
'BK;R
:ELH;EBLA>=:K>LHGL>A>K>BO>=KH$$/:;HM:MBL:L: >:MK> H %,GL:M>= L $> >GMBME>= BMHGBLHKL :G= />KOBL
=BGBLMK:MBHGH$$/ MA:M BMH>L GHM0K:
"KHH:G:OB=$./7:BEMHH:GAKL:@HO8
/>GM"KB=:R">;K:KR,)
0H=BK;RGRGM
:OB=
%GK>LHGL>MHRHKHLMK>GMBGBKR$./A:LMA>HEEHBG@
LM:M>>GM
0A>@HO>KG>GMA:LG>O>KGL:M>=GHKA:LBM>O>K;>>G
HK=>K>=MHGL:M>:GR;:L>=HG:=>M>KBG:MBHGMA:M
:MBL:L:GL:M>=
LBGABQAB;BM>=:G>GA:EH:MARHK@>G>K:E
;K:BG=BL>:L>!GA:EH:MAR:R;>:=BLLBHGH:G:KK:RHLRMHLBGBK>L
&97/-236./.099
-97:/8=+>/937+>/6C/8.?:A3>2+?>3=793=>3-
=C7:>97=,?>A/.989>>23=,+=3=
.>@:K=L
&// 1/8/KM " '>GG>=R &K :OB= 'BK;R )+--38/ 9??>3=7 /,+>/ 98>38?/= $""%*#0+* ,+/0 ">; +@+36+,6/ +>AMMABG@MHGHLMKM>GG>=RK:G==:OB=BK;RO::EMA $:G />KOL*H/E:BL(!%/">=E&ER+@+36+,6/+> AMMLL ;>EE*'/==//+6=9380=:L>A:KM
-
8/6/2019 Vaccine Study
25/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
:OB=H:G
+BHHGB:EMA.>LHKL:G=/>KOBL=BGBLMK:MBHG
0A>:MAHKL>KE>Q>=;R$$/ZL::K>GM=BLBGM>K>LMBG:G
:LLH MA>BLL>KMA>KH:MAHK.H;>KM'K:H:==K>LL>=:"K>>=HH%GHK:MBHG %&('38
?>3=7 !*0.!/ %* 0%/) (+# />M ,)AMM:=O>GMK>LBG:MBL;EH@LHMA:LBL:==>="HK:G>QKMHMA>>:BEL>>:ELH'>GG>=R'BK;R=?:
3ABE>K>
E>@:ELM:G=:K=HL:>:LLGMBB;EBLA>=:KMBLHG O:= HG K>OB> H GL:M>= KMLLBLHEBH>:LE>LK;>EE::G=)).O:L0A>
&//380G=BQ%%%
&//380G=BQ%AB@HO>KG>GM:E:G=L H MA> %,GL:M>= L :L : LHK H O:E:;E> BGHK:MBHG HGO:
-
8/6/2019 Vaccine Study
26/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
:MAHKL A:O> BG= LGMBLML :M MA> MA> %GLMBMM> H)>=B:G=MA>%,
. *$$B/96@521.@2@
-
8/6/2019 Vaccine Study
27/66
$+((*).+ ,)
8 (!!&*%$(&'"!&
-(&37
&$?:0'
&"-5)
6."/&374
"5
-56-:
*4.&/5"-%&7&-01.&/5)"4#&&/"33&45&%&%0&4/?541&","/%8*--
/&7&3
$0..6/*$"5&7&3#"--:
&%0&4/?53&410/%507&3#"-$0..6/*$"5*0/
&*4/05
50*-&553"*/&%&*44&-'%&4536$5*7&"/%7&3:%*''*$6-550."/"(&
&/&&%4
$0/45"/50/&0/0/&$"3&501305&$5)*.'
30.*/+63*/()*.4&-'"/%05)&34=
03&/4&/7
&$?:0'&"-5)
6."/&374
"5
-5&$
-
8/6/2019 Vaccine Study
28/66
$+((*).+ ,)
#!)%"!!'*%)* 7HE
"4BB=4AE
(42MH
>540;C7
D280;5D=2C8>
=8=68B4GCA4?A80C4
B748B
14;;864A4=C0=3B>505
40;C7
DC0;;H34?4=34=C>=>C74AB5>A74A20A40=3=443B
2>=BC0=
CBD?4AE8B8>=0=30BB8BC0=24
(748B=>=E4A10;1DCB86=BB4E4A0
;
F>A3BK
*=34AF>>3E
(42MH>540;C7
D=
A4B?>=34=C=>C43C70C)A0E8BMA3B8=3820C4C70C7
4BD5
54A435A>=B022>A38=6C>
A4B?>=
34=C0A
4=>CA4;0C43C>C74A4B83D0;B48ID
A438B>A34AK
(70A?=02:E
(42MH>540;C7
DFBC70C"460=4G7818CBB>A0;?A>1;4=0=3B>2
80;039DBCAF78278=
2;D34B7
40310=68=6
?D;;8=674A>F=708A
0=3B2A0C278=60CC78=6B=
BC0=C;HA438A42C43
4A38BAD?C8E40=3=>
=2>